1. Asadi-Lari, M., Tamburini, M., Gray, D. (2004). Patients' needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes, 2, pp. 32.
2. Bartolini, B., Bertoldi, S., Benedan, L., Galeone, C., Mariani, P., Sofia, F., Zenga, M. (2021). Development of an innovative methodology to define patient-designed Quality of Life: a new version of a well-known concept in healthcare. In Bruno Bertaccini,
3. Benedan, L., Hachem, M. El, Galeone, C., Mariani, P., Pilo, C., Tadini, G. (2022). Assessing the Quality of Life of patients with Epidermolysis Bullosa (EB): Development of a patient-centered questionnaire. In Book of short papers - 10th International Con
4. Boulkedid, R., Abdoul, H., Loustau, M., Sibony, O., Alberti, C. (2011). Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One, 6(6), e20476.
5. Centers for Disease Control and Prevention (2000). Measuring healthy days: Population assessment of health-related quality of life. Centers for Disease Control and Prevention, Atlanta, Georgia.
6. Pacinelli, A., (2008). Metodi per la Ricerca Sociale Partecipata, Franco Angeli, Milano.
7. Patrick, D.L., Deyo, R.A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Med Care, 27(3 Suppl), pp. S217-232.
8. Rabin, R., de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), pp. 337—342.
9. Selim, A.J., Rogers, W., Fleishman, J.A., Qian, S.X., Fincke, B.G., Rothendler, J.A., Kazis, L.E. (2009). Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res., 18(1), pp 43-52.
10. Trevelyan, E. G., Robinson, N. (2015). Delphi methodology in health research: How to do it? European Journal of Integrative Medicine, 7(4), pp. 423–428.
11. Ware, J. E., Jr., Gandek, B., Guyer, R., Deng, N. (2016). Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®). Health Quality Life Outcomes,
12. Warner, K., See, W., Haerry, D., Klingmann, I., Hunter, A., May, M. (2018). EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D. Front Med (Lausanne), 5, pp. 270.

Informazioni sul capitolo

Informazioni bibliografiche